Goodrx (GDRX) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$785.2M

Revenue (quarter)

$200.4M

Revenue growth (year over year)

−1.31%

Gross profit (trailing twelve months)

$713.2M

Gross margin

90.83%

Net income (trailing twelve months)

$16.2M

Net income (quarter)

$8.5M

Net income growth (year over year)

−33.54%

Net margin

2.07%

Return on equity

2.52%

EPS (trailing twelve months)

$0.06

Book value per share

$1.90

P/E (trailing twelve months)

73.06

Price to book

1.83

Debt to assets

72.36%

Payout ratio

—

Dividend yield

—

Company profile

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

• Is Goodrx (GDRX) profitable?

  Yes. Goodrx earned $16.2M in net income over the trailing twelve months, a net margin of 2.07%.

• How much revenue does Goodrx (GDRX) make?

  Goodrx generated $785.2M in revenue over the trailing twelve months, down 1.31% year over year.

• What is GDRX's P/E ratio?

  Goodrx trades at 73.1 times trailing twelve-month earnings, on an EPS of $0.06.

• How do I buy stock in Goodrx (GDRX)?

  GDRX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.